These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 24011443

  • 1. Depiction and characterization of liver lesions in whole body [¹⁸F]-FDG PET/MRI.
    Beiderwellen K, Gomez B, Buchbender C, Hartung V, Poeppel TD, Nensa F, Kuehl H, Bockisch A, Lauenstein TC.
    Eur J Radiol; 2013 Nov; 82(11):e669-75. PubMed ID: 24011443
    [Abstract] [Full Text] [Related]

  • 2. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T, Tatsumi M, Onishi H, Nakamoto A, Kim T, Hori M, Sakane M, Hori Y, Morii E, Hatazawa J, Tomiyama N.
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [Abstract] [Full Text] [Related]

  • 3. Respiratory-gated ¹⁸F-FDG PET/CT for the diagnosis of liver metastasis.
    Suenaga Y, Kitajima K, Aoki H, Okunaga T, Kono A, Matsumoto I, Fukumoto T, Tanaka K, Sugimura K.
    Eur J Radiol; 2013 Oct; 82(10):1696-701. PubMed ID: 23768610
    [Abstract] [Full Text] [Related]

  • 4. Diffusion-weighted imaging as part of hybrid PET/MRI protocols for whole-body cancer staging: does it benefit lesion detection?
    Buchbender C, Hartung-Knemeyer V, Beiderwellen K, Heusch P, Kühl H, Lauenstein TC, Forsting M, Antoch G, Heusner TA.
    Eur J Radiol; 2013 May; 82(5):877-82. PubMed ID: 23428414
    [Abstract] [Full Text] [Related]

  • 5. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S.
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [Abstract] [Full Text] [Related]

  • 6. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
    Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.
    Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
    [Abstract] [Full Text] [Related]

  • 7. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
    Eiber M, Takei T, Souvatzoglou M, Mayerhoefer ME, Fürst S, Gaertner FC, Loeffelbein DJ, Rummeny EJ, Ziegler SI, Schwaiger M, Beer AJ.
    J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
    [Abstract] [Full Text] [Related]

  • 8. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [Abstract] [Full Text] [Related]

  • 9. Hybrid imaging for detection of carcinoma of unknown primary: A preliminary comparison trial of whole-body PET/MRI versus PET/CT.
    Ruhlmann V, Ruhlmann M, Bellendorf A, Grueneisen J, Sawicki LM, Grafe H, Forsting M, Bockisch A, Umutlu L.
    Eur J Radiol; 2016 Nov; 85(11):1941-1947. PubMed ID: 27776644
    [Abstract] [Full Text] [Related]

  • 10. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ, Poeppel TD, Hartung-Knemeyer V, Buchbender C, Kuehl H, Bockisch A, Lauenstein TC.
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [Abstract] [Full Text] [Related]

  • 11. Integrated whole-body PET/MR hybrid imaging: clinical experience.
    Quick HH, von Gall C, Zeilinger M, Wiesmüller M, Braun H, Ziegler S, Kuwert T, Uder M, Dörfler A, Kalender WA, Lell M.
    Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
    Grueneisen J, Beiderwellen K, Heusch P, Gratz M, Schulze-Hagen A, Heubner M, Kinner S, Forsting M, Lauenstein T, Ruhlmann V, Umutlu L.
    Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
    [Abstract] [Full Text] [Related]

  • 13. Whole-body [¹⁸F]FDG PET/MRI vs. PET/CT in the assessment of bone lesions in oncological patients: initial results.
    Beiderwellen K, Huebner M, Heusch P, Grueneisen J, Ruhlmann V, Nensa F, Kuehl H, Umutlu L, Rosenbaum-Krumme S, Lauenstein TC.
    Eur Radiol; 2014 Aug; 24(8):2023-30. PubMed ID: 24907940
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of PET and MR datasets in integrated 18F-FDG PET/MRI: A comparison of different MR sequences for whole-body restaging of breast cancer patients.
    Grueneisen J, Sawicki LM, Wetter A, Kirchner J, Kinner S, Aktas B, Forsting M, Ruhlmann V, Umutlu L.
    Eur J Radiol; 2017 Apr; 89():14-19. PubMed ID: 28267530
    [Abstract] [Full Text] [Related]

  • 15. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J, Ma Q, Guo Q, Sun H, Zhang S, Liu C, Zhai W.
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [Abstract] [Full Text] [Related]

  • 16. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
    García Vicente AM, Domínguez Ferreras E, Sánchez Pérez V, Poblete García VM, Villa Guzmán JC, Jiménez Aragón F, Pineda Pineda MD, Molino Trinidad C, Soriano Castrejón Á.
    Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
    [Abstract] [Full Text] [Related]

  • 17. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 18. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
    Cantwell CP, Setty BN, Holalkere N, Sahani DV, Fischman AJ, Blake MA.
    J Comput Assist Tomogr; 2008 Dec; 32(5):738-44. PubMed ID: 18830103
    [Abstract] [Full Text] [Related]

  • 19. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
    Kong EJ, Chun KA, Bom HS, Lee J, Lee SJ, Cho IH.
    Hell J Nucl Med; 2014 Dec; 17(3):171-6. PubMed ID: 25397622
    [Abstract] [Full Text] [Related]

  • 20. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
    Sawicki LM, Grueneisen J, Buchbender C, Schaarschmidt BM, Gomez B, Ruhlmann V, Wetter A, Umutlu L, Antoch G, Heusch P.
    J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.